Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousStem CellsTransplantation ConditioningPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanCombined Modality TherapyGraft vs Host DiseaseTreatment OutcomeRemission InductionHematopoietic Stem CellsSalvage TherapyHematologic NeoplasmsMyeloablative AgonistsDisease-Free SurvivalRecurrenceBone Marrow TransplantationHematopoietic Stem Cell MobilizationCyclophosphamideHodgkin DiseaseEtoposideEmbryonic Stem CellsCytarabineSurvival RateLymphoma, Non-HodgkinBusulfanAdult Stem CellsSurvival AnalysisCarmustineWhole-Body IrradiationRetrospective StudiesTransplantation ChimeraVincristineMesenchymal Stem Cell TransplantationGraft SurvivalThiotepaBone Marrow PurgingPluripotent Stem CellsLymphoma, Mantle-CellAntigens, CD34PrognosisTissue DonorsAmyloidosisFollow-Up StudiesDoxorubicinTime FactorsStem Cell NicheAntibodies, Monoclonal, Murine-DerivedLeukemia, Myeloid, AcuteCell DifferentiationAntineoplastic AgentsDexamethasoneBoronic AcidsNeoplasm, ResidualLymphoma, FollicularNeural Stem CellsGraft vs Leukemia EffectPyrazinesGranulocyte Colony-Stimulating FactorInduced Pluripotent Stem CellsCord Blood Stem Cell TransplantationMesenchymal Stromal CellsAntineoplastic Agents, AlkylatingThalidomideHistocompatibility TestingVidarabineMyelodysplastic SyndromesLymphoma, T-Cell, PeripheralAutograftsLymphomaGraft vs Tumor EffectLiver TransplantationLeukapheresisIfosfamideImmunosuppressive AgentsMultipotent Stem CellsLeukemiaInduction ChemotherapyPrednisoneCell TransplantationPodophyllotoxinStem Cell FactorHistocompatibilityBone Marrow CellsLymphoma, Large B-Cell, DiffuseLymphocyte TransfusionMaintenance ChemotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaCells, CulturedT-LymphocytesLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsHematopoiesisProspective StudiesAcute Disease